Evidence map›Paper›PMID 42128427›Full record

ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2026

Mtb-Specific Interferon-Gamma ELISpot Assays Have Greater Sensitivity for Detecting Mtb Infection Compared to Tuberculin Skin Test in a Cohort of Experimentally M. tuberculosis-Infected Macaques.

Marshall A Malin, Pauline Maiello, H Jacob Borish, Daniel Fillmore, Jaime Tomko, Kara Kracinovsky, Jennifer Schober, Joshua Mattila, Edwin C Klein, Anita M Trichel and 8 more

Abstract read
In one paragraph

Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Marshall A Malin1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Pauline Maiello1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
H Jacob Borish1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Daniel Fillmore1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jaime Tomko1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Kara Kracinovsky1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jennifer Schober1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Joshua Mattila3Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Edwin C Klein4Division of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh, Pennsylvania.
Anita M Trichel4Division of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh, Pennsylvania.
Anna Skorupski4Division of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jaymahalaxmi R Geddedu-Hurdial5Bioculture (Mauritius) Ltd, Senneville, Rivière des Anguilles, Mauritiu; and.
Sam Narainapoullé3Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Mark Rodgers1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Reagan Walker4Division of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh, Pennsylvania.
JoAnne L Flynn1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Charles A Scanga1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Philana Ling Lin2Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis outbreaks in nonhuman primate (NHP) colonies can result in disastrous financial, scientific, animal welfare, and public health outcomes. Tuberculin skin testing (TST) has been the standard diagnostic method for identifying Mycobacterium tuberculosis (Mtb) infection in NHPs but has limited sensitivity and specificity. In humans, Mtb-specific interferon-γ release assays (IGRAs) have become the preferred diagnostic method, overcoming significant limitations of the TST. We compared the diagnostic qualities of the TST and IGRA in a cohort of 673 rhesus and cynomolgus macaques with experimental Mtb infection. Serial TST and IGRA data were curated retrospectively for animals before and after Mtb infection and temporally matched to assess sensitivity, specificity, and agreement between the 2 tests. The overall sensitivity of the IGRA was 0.84 compared with 0.49 sensitivity of the TST test in detecting Mtb infection. Specificity of the IGRA and the TST was 0.83 and 1.0, respectively, with an overall agreement rate of 72% between the 2 tests. Sensitivity peaked at 3-5 weeks postinfection for TST and 5-7 weeks for IGRA. Data from a second cohort of animals (n = 227) that were not experimentally infected with Mtb, but for whom testing was done for screening and investigational purposes, demonstrated an agreement rate of 96%. To our knowledge, this is the largest reported comparison of TST and IGRA testing in NHPs. Although IGRAs are more labor intensive than TSTs, our data suggest that IGRAs have better diagnostic accuracy in detecting Mtb infection. Our data also suggest that the threshold for a positive TST could be lowered to improve sensitivity.

Indexed as

AFB, acid-fast bacilliBCG, Bacillus Calmette-GuerinELISpot, enzyme linked immunospotIGRA, interferon-gamma release assayMOT, mammalian old tuberculinMtb, Mycobacterium tuberculosisPBMC, peripheral blood mononuclear cellsP + I, phorbol 12,13-dibutyrate and ionomycinPPD, purified protein derivativeROC, receiver operating characteristicSFU, spot-forming unitTB, tuberculosisTST, tuberculin skin test

Identifiers

PMID42128427
PMCPMC13446392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.